(Q33409225)

26 July 2017

title

Designer cytokine hyper interleukin 11 (H11) is a megakaryopoietic factor (English)

1 reference

26 July 2017

Hanna Dams-Kozlowska

1

0 references

Andrzej Mackiewicz

series ordinal

4

object named as

Andrzej Mackiewicz

1 reference

26 July 2017

author name string

Eliza Kwiatkowska-Borowczyk

series ordinal

2

1 reference

26 July 2017

Katarzyna Gryska

series ordinal

3

1 reference

26 July 2017

language of work or name

English

0 references

publication date

9 July 2013

1 reference

International Journal of Medical Sciences

26 July 2017

published in

1 reference

26 July 2017

volume

10

1 reference

26 July 2017

issue

9

1 reference

26 July 2017

page(s)

1157-1165

1 reference

A designer hyper interleukin 11 (H11) is a biologically active cytokine.

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714392

Hyper-interleukin-11 novel designer molecular adjuvant targeting gp130 for whole cell cancer vaccines.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714392

In vitro megakaryocyte production and platelet biogenesis: state of the art

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714392

Management of chemotherapy-induced thrombocytopenia: current status of thrombopoietic agents

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714392

Cytokines for the treatment of thrombocytopenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714392

CD41+/CD45+ cells without acetylcholinesterase activity are immature and a major megakaryocytic population in murine bone marrow

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714392

Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714392

Recombinant human thrombopoietin: basic biology and evaluation of clinical studies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714392

The role of recombinant interleukin 11 in megakaryocytopoiesis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714392

Interleukin-11: review of molecular, cell biology, and clinical use.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714392

Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714392

Thrombocytopenia in c-mpl-deficient mice

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714392

Interleukin-11 stimulates multiple phases of erythropoiesis in vitro

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714392

Interleukin-11 enhances human megakaryocytopoiesis in vitro

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714392

Emerging treatments for thrombocytopenia: increasing platelet production

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714392

Hematopoietic, immunomodulatory and epithelial effects of interleukin-11.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714392

Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714392

Recombinant human interleukin-11 synergizes with steel factor and interleukin-3 to promote directly the early stages of murine megakaryocyte development in vitro

31 October 2018

1 reference

12 December 2020

Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets

1 reference

12 December 2020

Interleukin-6 enhances murine megakaryocytopoiesis in serum-free culture

1 reference

12 December 2020

Leukemia inhibitory factor and interleukin-11 promote maturation of murine and human megakaryocytes in vitro

1 reference

12 December 2020

Synergistic effects of interleukin-11 with other growth factors on the expansion of murine hematopoietic progenitors and maintenance of stem cells in liquid culture

1 reference

12 December 2020

IL-11 directly stimulates murine and human erythroid burst formation in semisolid cultures

1 reference

12 December 2020

Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3

1 reference

12 December 2020

Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3

1 reference

12 December 2020

Recombinant human interleukin-11 directly promotes megakaryocytopoiesis in vitro

1 reference

12 December 2020

Identifiers

DOI

10.7150/IJMS.5638

1 reference

26 July 2017

1 reference

26 July 2017

1 reference